Shanon Lim (King’s College London, United Kingdom) explained during his presentation at the ERS congress that although there is a lot of knowledge on exposure to traffic pollution, hardly any data is available on the influence air pollutants have on professional drivers [1]. In the Diesel Exposure Mitigation Study, a collaboration between researchers at King’s College and researchers at Queen Mary University of London, 140 professional drivers from a range of occupations working in central London were recruited. In addition to taxi drivers, couriers, truck drivers, waste removal and emergency service workers took part in the trial. The drivers were asked to carry black carbon monitors for a period of 96 hours. The monitors measured exposure levels once every minute. Drivers were also asked about the type of vehicle they drive, their working hours, and whether they drive with their windows or air vents open.
On average, professional drivers were exposed to 4.1 µg/m3 of black carbon while driving, which was around 4 times higher than their exposure at home (1.1 µg/m3). Levels measured at home were similar to those experienced by office workers in big cities at their desks. From all the professional workers in the study, taxi drivers had the highest levels of exposure (on average 6.5 µg/m3), and emergency services workers the lowest levels of exposure (on average 2.8 µg/m3). However, all professional drivers experienced extremely high spikes in exposure to black carbon, often exceeding 100 µg/m3 and lasting up to half an hour.
As Mr Lim pointed out, the exposure levels of professional drivers were higher than those measured at a busy London roadside (3.1 µg/m3 on average at Marylebone Road). So, being inside a vehicle does not offer any protection from air pollution. On the contrary, air pollution seems to get trapped inside the vehicle for extended periods of time. However, the study showed a simple way to reduce exposure: keeping windows closed while working halved the levels of black carbon. The type of vehicle and the choice of route could also lower exposure.
As a next step, the researchers will investigate possible strategies to protect drivers, such as the use of air filters to minimise work-related health-risks.
- Lim G et al. Abstract OA486, ERS 2019, 29 Sept-2 Oct, Madrid, Spain.
Posted on
Previous Article
« Alternative nicotine delivery products: no help in smoking cessation Next Article
Pneumococcal vaccines: an effective way to reduce COPD hospitalisations »
« Alternative nicotine delivery products: no help in smoking cessation Next Article
Pneumococcal vaccines: an effective way to reduce COPD hospitalisations »
Table of Contents: ERS 2019
Featured articles
Letter from the Editor
Interview with ERS president Prof. Tobias Welte
Holistic View on Asthma
Holistic view on asthma
COPD Management
COPD patients derive clinical benefit from β-blockers
COPD patients harbouring Pseudomonas Aeruginosa face high risk of hospitalisation
One blood eosinophil count is sufficient to guide ICS therapy
Female COPD patients frequently suffer from anxiety and depression
Dual bronchodilation improves ventilation dynamics in COPD patients
Vaping
Vaping impairs innate immune response of the airway
Alternative nicotine delivery products: no help in smoking cessation
Air Pollution
Pregnant women and their offspring: a high-risk group for air pollution
Taxi drivers exposed to highest levels of black carbon pollution
Infectious Respiratory Disease: the Role of Vaccines
Vaccines show multiple positive effects with respect to respiratory health
Pneumococcal vaccines: an effective way to reduce COPD hospitalisations
Interstitial Lung Disease
Antifibrotic therapy slows disease progression in ILD
Reduction of FVC decline in systemic sclerosis-associated ILD
Registry confirms nintedanib efficacy under real-life conditions
Best of the Posters
Fever during immunotherapy for NSCLC associated with shorter PFS
Smart shirt as a device to measure tidal volumes in real-life setting
Exercise with virtual reality beneficial for COPD patients
NSCLC: A new way to evaluate hilar and mediastinal lymph nodes
COPD patients do not benefit from azithromycin therapy longer than a year
Novel Developments in Infectious Disease
Long-term azithromycin decreases exacerbations in primary ciliary dyskinesia
Predicting community-acquired pneumonia outcomes by microRNA testing
Pulmonary Vascular Disease
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
Related Articles
October 20, 2021
Can CBD oil help shrink lung tumors?
September 13, 2017
Letter from the Editor
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy